Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1944 participants.
Also called NCT07611747
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,944 participants
- Registry
-
NCT07611747 -
2025-521086-28-00
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT07611747. Randomized; no masking; primary purpose prevention. Start 2026-04-22 (actual); primary completion 2031-04-22 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
- Acronym
- PREVENER
- Condition
- Rheumatoid Arthritis (RA)
- Condition
- Psoriatic Arthritis (PsA)
- Condition
- Systemic Lupus Erythematosus (SLE)
- Condition
- Carotid Artery Diseases
- Condition
- Cardio Vascular Disease
- Condition
- Atheroscleroses
- Condition
- Axial Spondyloarthritis
- Intervention (Diagnostic test)
- Carotid Ultrasound
- Intervention (Drug)
- High-intensity lipid-lowering therapy
- Intervention (Other)
- Standard care according to ESC 2021 guidelines
- Lead sponsor
- Instituto de Investigación Marqués de Valdecilla
Record details
- Record id
cardio:ct-nct07611747- Content hash
4720c44743f7fd8646162f86394779c995a62d594348bd1ba54920e149c95503